Loading, please wait....jpg)
For the best possible experience in completing this homestudy and watching the required video recording, we recommend always using the most current software that is available for your operating system.
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
CE participation will be provided to CPE Monitor within 60 days of the CE activity upon CE registration, confirmation of participation for the entire activity, and completion of online learning assessment questions and speaker evaluation administered post-session.
Support/Credits
There are 2 steps to completing this Homestudy CE:
Step 1: Watch the entire video recording of the activity.
Step 2: Click on "Take the Test" to complete the post-test and evaluation.
Please Note: A handout is provided. Please print it out and follow along with the audio recording.
Objectives
- Examine the rationale for adopting biosimilar oncology therapies into health systems
- Review how health systems can use formulary processes to integrate biosimilars into practice
- Evaluate the policy and economic impact of biosimilars on health systems
Speaker(s)/Author(s)
|
Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
|
Activity Number
0122-0000-21-016-H01-P/T
Release Date:
Apr 12, 2021
Credit Expiration Date:
Apr 12, 2024
CE Hours
1.00